Get the early sign-up offer by registering before July 31
Final registration closes on August 17
Final registration closes on August 17
Across Europe, world-class cancer research discoveries are being made – yet too often they take too long to reach patients. The gap between research, decision-making, and real-world impact remains one of our greatest missed opportunities.
Momentum brings together a carefully curated group of leaders from across sectors -
policymakers, healthcare leaders, patient representatives, researchers, civil society, industry and investors - all with a shared ambition: to accelerate Europe’s action on cancer.
Through roundtable discussions and co-creation sessions, participants engage
directly with the barriers holding progress back and contribute to shaping solutions.
Selected speakers will offer perspectives on key issues such as funding, regulation,
data, clinical trials and the uptake of innovation.
If you want to be part of shaping a more competitive Europe that delivers faster,
better outcomes for patients – this is where that work begins.
Welcome to Momentum.
"The bottleneck is time. Every year we spend moving a discovery through regulatory, reimbursement, and clinical trial bureaucracies is a year patients don’t have. The next breakthrough won’t come from a single lab – it will come from collapsing the distance between discovery and patient. [...] I want to leave Sweden with at least one conversation that changes how I think about something. Not panels - conversations."
Deputy Director-General: Planet, People and Science for Policy, Directorate-General for Research and Innovation, European Commission
CEO, Cancer Patient Europe and
Patient Advocacy Expert and Advisor to the Board of Pancreatic Cancer Europe
Chairman and Scientific Director, German Cancer Research Center (DKFZ).
President, European Academy of Cancer Sciences (EACS)
Biobanking and Biomolecular Resources Research Infrastructure – European Research Infrastructure Consortium (BBMRI-ERIC).
Helsinki University and Umeå University, and Chair of the The Swedish Cancer Society Research Board
The conference will feature ongoing reflections from a panel of leading journalists, including:
Global Health Editor - Financial Times
Associate Editor - Dagens industri
You are using an outdated browser. Please upgrade your browser to improve your experience.